Oscar Health, Inc. $OSCR Stock Position Raised by Quantinno Capital Management LP

Quantinno Capital Management LP increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 338.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,717 shares of the company’s stock after acquiring an additional 104,770 shares during the quarter. Quantinno Capital Management LP’s holdings in Oscar Health were worth $1,557,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of OSCR. Vanguard Group Inc. lifted its position in Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock valued at $297,477,000 after purchasing an additional 540,851 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Oscar Health by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after purchasing an additional 116,430 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in shares of Oscar Health by 1,097.8% during the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 237,882 shares of the company’s stock worth $3,418,000 after acquiring an additional 218,022 shares during the period. BIT Capital GmbH grew its stake in Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares during the period. Finally, Simplify Asset Management Inc. purchased a new stake in shares of Oscar Health in the 4th quarter worth about $2,948,000. Institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In other news, Director Mario Schlosser sold 880,000 shares of the company’s stock in a transaction on Tuesday, June 23rd. The stock was sold at an average price of $29.38, for a total transaction of $25,854,400.00. Following the transaction, the director directly owned 480,866 shares of the company’s stock, valued at $14,127,843.08. This represents a 64.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Liang sold 12,475 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider directly owned 259,057 shares in the company, valued at $5,683,710.58. This trade represents a 4.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 3,562,466 shares of company stock valued at $102,829,815. Insiders own 22.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on OSCR shares. Wells Fargo & Company restated a “mixed” rating on shares of Oscar Health in a report on Wednesday. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wolfe Research began coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company. Finally, Piper Sandler reissued an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $25.44.

Oscar Health Price Performance

Shares of OSCR opened at $29.79 on Thursday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.10. The company has a market capitalization of $8.98 billion, a P/E ratio of 21.28, a price-to-earnings-growth ratio of 0.58 and a beta of 2.36. The firm has a 50 day moving average of $29.35 and a 200 day moving average of $20.67. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 44.96% and a net margin of 3.60%.The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same period in the prior year, the firm posted ($0.89) EPS. The firm’s quarterly revenue was up 70.4% on a year-over-year basis. As a group, equities research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.